who should not take a glp 1 GLP-1 Weight Loss Medications: What You Need to Know Use of GLP-1 drugs early

The current generation of GLP-1 receptor agonists includes: Semaglutide (weekly subcutaneous injection or oral formulation) Liraglutide (daily subcutaneous injection) Tirzepatide (dual GLP-1/GIP receptor agonist, weekly subcutaneous injection) Each of these GLP-1 agents carries a distinct pharmacological profile, and the optimal choice depends on a patients clinical history, metabolic risk factors, and therapeutic goals a determination best made in consultation with a physician experienced in metabolic and longevity medicine

Bracke, M.E., Depypere, H.T., Boterberg, T., Van Marck, V.L., Vennekens, K.L.M., Vanluchene, E., Nuytinck, M., Serreyn, R

The creatine:phosphocreatine system plays an essential role in ongoing energy metabolism by serving as a reservoir for phosphate moieties in their transfer back and forth from ATP to ADP (81)

Liu W-T, Jing Y-Y, Yu G-F, Chen H, Han Z-P, Yu D-D, Fan Q-M, Ye F, Li R, Gao L, et al